BRPI1008836B8 - dispositivo e método médicos para proporcionar informações de controle glicêmico - Google Patents
dispositivo e método médicos para proporcionar informações de controle glicêmicoInfo
- Publication number
- BRPI1008836B8 BRPI1008836B8 BRPI1008836A BRPI1008836A BRPI1008836B8 BR PI1008836 B8 BRPI1008836 B8 BR PI1008836B8 BR PI1008836 A BRPI1008836 A BR PI1008836A BR PI1008836 A BRPI1008836 A BR PI1008836A BR PI1008836 B8 BRPI1008836 B8 BR PI1008836B8
- Authority
- BR
- Brazil
- Prior art keywords
- data
- glycemic control
- validation
- medical device
- serves
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/30—Authentication, i.e. establishing the identity or authorisation of security principals
- G06F21/31—User authentication
- G06F21/34—User authentication involving the use of external additional devices, e.g. dongles or smart cards
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Emergency Medicine (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Theoretical Computer Science (AREA)
- Computer Security & Cryptography (AREA)
- Urology & Nephrology (AREA)
- Ecology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Software Systems (AREA)
- Computer Hardware Design (AREA)
- General Engineering & Computer Science (AREA)
- Artificial Intelligence (AREA)
Abstract
dispositivo e método médicos para proporcionar informações de controle glicêmico. a presente invenção refere-se a um dispositivo médico que serve para proporcionar informações para controle glicêmico, sendo que o dispositivo compreende meios de armazenamento dispostos para armazenar dados, meios de recepção dispostos para receber dados de valor de glicose sanguínea e dados de segurança, meios de processamento de dados dispostos para executar uma primeira função de processamento que serve para modificar dados recuperados a partir dos meios de armazenamento e executar uma segunda função de processamento que serve para proporcionar informações para controle glicêmico com base nos dados de valor de glicose sanguínea e nos dados recuperados a partir dos meios de armazenamento, meios de validação dispostos para validar os dados de segurança recebidos e proporcionar dados de validação correspondentes à validação dos dados de segurança recebidos, e meios de segurança dispostos para controlar uma execução de pelo menos uma função predeterminada entre as primeira e segunda funções de processamento com base nos dados de validação.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122020016567-7A BR122020016567B1 (pt) | 2009-02-04 | 2010-02-03 | Sistema médico para proporcionar controle glicêmico |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09001560.3 | 2009-02-04 | ||
EP09001560 | 2009-02-04 | ||
PCT/EP2010/051264 WO2010089304A1 (en) | 2009-02-04 | 2010-02-03 | Medical device and method for providing information for glycemic control |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI1008836A2 BRPI1008836A2 (pt) | 2016-03-15 |
BRPI1008836B1 BRPI1008836B1 (pt) | 2020-12-01 |
BRPI1008836B8 true BRPI1008836B8 (pt) | 2021-06-22 |
Family
ID=40626791
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1008836A BRPI1008836B8 (pt) | 2009-02-04 | 2010-02-03 | dispositivo e método médicos para proporcionar informações de controle glicêmico |
BR122020016567-7A BR122020016567B1 (pt) | 2009-02-04 | 2010-02-03 | Sistema médico para proporcionar controle glicêmico |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122020016567-7A BR122020016567B1 (pt) | 2009-02-04 | 2010-02-03 | Sistema médico para proporcionar controle glicêmico |
Country Status (11)
Country | Link |
---|---|
US (2) | US20120053843A1 (pt) |
EP (2) | EP2393412B1 (pt) |
JP (1) | JP5677321B2 (pt) |
CN (2) | CN102369029A (pt) |
AU (1) | AU2010210181B2 (pt) |
BR (2) | BRPI1008836B8 (pt) |
CA (2) | CA2750049C (pt) |
DK (2) | DK3254616T3 (pt) |
HK (1) | HK1248083A1 (pt) |
IL (1) | IL214317A (pt) |
WO (1) | WO2010089304A1 (pt) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103400028B (zh) | 2008-04-04 | 2017-04-12 | 海吉雅有限公司 | 用于优化患者的胰岛素剂量方案的装置 |
US10624577B2 (en) | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
US9220456B2 (en) | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
ES2650621T3 (es) | 2008-10-17 | 2018-01-19 | Sanofi-Aventis Deutschland Gmbh | Combinación de una insulina y un agonista de GLP-1 |
WO2010056718A2 (en) | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
US9117015B2 (en) | 2008-12-23 | 2015-08-25 | Roche Diagnostics Operations, Inc. | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device |
US10456036B2 (en) | 2008-12-23 | 2019-10-29 | Roche Diabetes Care, Inc. | Structured tailoring |
US8849458B2 (en) | 2008-12-23 | 2014-09-30 | Roche Diagnostics Operations, Inc. | Collection device with selective display of test results, method and computer program product thereof |
EP4246522A3 (en) | 2008-12-23 | 2023-11-08 | Roche Diabetes Care GmbH | Structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereof |
US9918635B2 (en) | 2008-12-23 | 2018-03-20 | Roche Diabetes Care, Inc. | Systems and methods for optimizing insulin dosage |
US20120011125A1 (en) | 2008-12-23 | 2012-01-12 | Roche Diagnostics Operations, Inc. | Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device |
US10437962B2 (en) | 2008-12-23 | 2019-10-08 | Roche Diabetes Care Inc | Status reporting of a structured collection procedure |
EP2393412B1 (en) | 2009-02-04 | 2017-08-30 | Sanofi-Aventis Deutschland GmbH | Medical device and method for providing information for glycemic control |
PE20121362A1 (es) | 2009-11-13 | 2012-10-17 | Sanofi Aventis Deutschland | Composicion farmaceutica que comprende despro36exendina-4(1-39)-lys6-nh2, insulina gly(a21)-arg(b31)-arg(b32) y metionina |
TWI468171B (zh) | 2009-11-13 | 2015-01-11 | Sanofi Aventis Deutschland | 含glp-1激動劑及甲硫胺酸之醫藥組成物 |
US8532933B2 (en) | 2010-06-18 | 2013-09-10 | Roche Diagnostics Operations, Inc. | Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers |
RU2546520C2 (ru) | 2010-08-30 | 2015-04-10 | Санофи-Авентис Дойчланд Гмбх | Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа |
US20120173151A1 (en) | 2010-12-29 | 2012-07-05 | Roche Diagnostics Operations, Inc. | Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels |
US10448869B2 (en) | 2011-05-13 | 2019-10-22 | Roche Diabetes Care, Inc. | User-defined structured testing for use in diabetes care |
US8755938B2 (en) | 2011-05-13 | 2014-06-17 | Roche Diagnostics Operations, Inc. | Systems and methods for handling unacceptable values in structured collection protocols |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
US8766803B2 (en) | 2011-05-13 | 2014-07-01 | Roche Diagnostics Operations, Inc. | Dynamic data collection |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
WO2013037754A2 (en) | 2011-09-13 | 2013-03-21 | Novo Nordisk A/S | Adaptive system for optimizing a drug dosage regimen over time |
BR112014010200A2 (pt) * | 2011-10-28 | 2020-10-27 | Sanofi-Aventis Deutschland Gmbh | combinação farmacêutica, bem como seu uso na preparação de um medicamento para o tratamento de diabetes tipo 2 |
US8886619B2 (en) | 2011-12-29 | 2014-11-11 | Roche Diagnostics Operations, Inc. | Structured test adherence management for manual data entry systems |
US10258293B2 (en) | 2011-12-29 | 2019-04-16 | Roche Diabetes Care, Inc. | User interface features for a diabetes management application |
AR092077A1 (es) * | 2012-08-10 | 2015-03-18 | Sanofi Aventis Deutschland | Sistema medico |
US10003545B2 (en) * | 2013-04-26 | 2018-06-19 | Roche Diabetes Care, Inc. | Mobile phone application for diabetes care with medical feature activation |
DK2994180T3 (da) * | 2013-05-07 | 2019-12-09 | Sanofi Aventis Deutschland | Hjælpeanordning til fastgøring til en injektionsanordning |
US9710604B2 (en) | 2013-06-27 | 2017-07-18 | Lifescan, Inc. | Analyte meter with operational range configuration technique |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
EP2966582A1 (en) | 2014-07-11 | 2016-01-13 | Sanofi-Aventis Deutschland GmbH | Titration of basal insulin with two modes |
ES2811086T3 (es) * | 2014-09-16 | 2021-03-10 | Medituner Ab | Sistema de dosificación controlado por ordenador |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
AU2015339576B2 (en) | 2014-10-27 | 2020-02-06 | Aseko, Inc. | Subcutaneous outpatient management |
RS64300B1 (sr) | 2014-12-12 | 2023-07-31 | Sanofi Aventis Deutschland | Formulacija fiksnog odnosa insulin glargina/liksisenatida |
CN107427635A (zh) * | 2015-01-26 | 2017-12-01 | 伯克顿迪金森公司 | 智能便携式输注泵 |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
CN104751037B (zh) * | 2015-04-10 | 2018-06-12 | 无锡海斯凯尔医学技术有限公司 | 医疗检测设备的使用控制方法、系统和医疗检测设备 |
WO2017031440A1 (en) | 2015-08-20 | 2017-02-23 | Aseko, Inc. | Diabetes management therapy advisor |
US20170053552A1 (en) | 2015-08-21 | 2017-02-23 | Medtronic Minimed, Inc. | Management and prioritization of the delivery of glycemic insight messages |
DK3352818T3 (da) * | 2015-09-23 | 2020-03-16 | Sanofi Aventis Deutschland | Anordning til fastgørelse til en injektionsanordning |
MX2018008822A (es) * | 2016-01-22 | 2018-09-21 | Hoffmann La Roche | Metodo para configurar dispositivo de gestion de diabetes por un profesional de la salud. |
CN109863560B (zh) | 2016-08-25 | 2023-11-17 | 诺和诺德股份有限公司 | 基础胰岛素滴定的起始工具包 |
US11579145B2 (en) | 2016-10-17 | 2023-02-14 | Reliant Immune Diagnostics, Inc. | System and method for image analysis of medical test results |
US11693002B2 (en) | 2016-10-17 | 2023-07-04 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type |
US11107585B2 (en) | 2016-10-17 | 2021-08-31 | Reliant Immune Diagnostics, Inc | System and method for a digital consumer medical wallet and storehouse |
US11802868B2 (en) | 2016-10-17 | 2023-10-31 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results |
US11651866B2 (en) | 2016-10-17 | 2023-05-16 | Reliant Immune Diagnostics, Inc. | System and method for real-time insurance quote in response to a self-diagnostic test |
US9857372B1 (en) * | 2016-10-17 | 2018-01-02 | Reliant Immune Diagnostics, LLC | Arbovirus indicative birth defect risk test |
US10902951B2 (en) | 2016-10-17 | 2021-01-26 | Reliant Immune Diagnostics, Inc. | System and method for machine learning application for providing medical test results using visual indicia |
CN110012675B (zh) | 2016-11-29 | 2024-02-27 | 诺和诺德股份有限公司 | 用于基础率滴定的起始套件 |
CN110235205A (zh) | 2016-12-23 | 2019-09-13 | 赛诺菲-安万特德国有限公司 | 用于支持健康控制的数据管理单元 |
JP7196077B2 (ja) * | 2016-12-23 | 2022-12-26 | サノフィ-アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 健康管理を支えるためのデータ管理ユニット |
EP3559837A1 (en) | 2016-12-23 | 2019-10-30 | Sanofi-Aventis Deutschland GmbH | Data management unit for supporting health control |
DK3618713T3 (da) | 2017-05-05 | 2022-01-24 | Lilly Co Eli | Styring af fysiologisk glucose i lukket sløjfe |
US20180317769A1 (en) * | 2017-05-08 | 2018-11-08 | Sajid Khan | System and method for real time blood glucose monitoring and response |
WO2019115358A1 (en) | 2017-12-11 | 2019-06-20 | Sanofi | A device for managing a medication regime |
US11901060B2 (en) | 2017-12-21 | 2024-02-13 | Ypsomed Ag | Closed loop control of physiological glucose |
WO2023014412A1 (en) * | 2021-08-03 | 2023-02-09 | Tandem Diabetes Care, Inc. | Systems and methods for alternate modes in automated insulin delivery for diabetes therapy |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
EP1131118A1 (de) | 1997-12-19 | 2001-09-12 | Phiscience GmbH, Entwicklung von Sensoren | Tragbare vorrichtung und verfahren zur mobilen medikamentenversorgung mit drahtloser übermittlung von daten zur steuerung bzw. programmierung |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6554798B1 (en) * | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
AU7780600A (en) | 1999-10-01 | 2001-05-10 | Glaxo Group Limited | Patient data monitoring system |
IL159460A0 (en) | 2001-07-09 | 2004-06-01 | Novo Nordisk As | Method and system for controlling data information between two portable medical apparatuses |
US6544212B2 (en) | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
US20050043965A1 (en) | 2001-11-28 | 2005-02-24 | Gabriel Heller | Methods and apparatus for automated interactive medical management |
US7204823B2 (en) | 2001-12-19 | 2007-04-17 | Medtronic Minimed, Inc. | Medication delivery system and monitor |
US20030212379A1 (en) | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
US8504179B2 (en) * | 2002-02-28 | 2013-08-06 | Smiths Medical Asd, Inc. | Programmable medical infusion pump |
CN100466965C (zh) * | 2002-08-13 | 2009-03-11 | 弗吉尼亚大学专利基金会 | 用于处理自我监测血糖(smbg)数据从而提高糖尿病患者自我管理的方法、系统和计算机程序产品 |
EP2327359B1 (en) | 2002-08-13 | 2015-01-21 | University Of Virginia Patent Foundation | Method, system, and computer program product for processing of self-monitoring blood glucose (smbg) data to enhance diabetic self-management |
US20040122353A1 (en) * | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
DE602004028143D1 (de) | 2003-10-13 | 2010-08-26 | Novo Nordisk As | Gerät und verfahren zur bestimmung eines physiologischen zustands |
US8518021B2 (en) * | 2004-05-27 | 2013-08-27 | Baxter International Inc. | Apparatus and method for therapeutic delivery of medication |
CN1304844C (zh) * | 2004-12-09 | 2007-03-14 | 上海交通大学 | 带血糖浓度趋势曲线显示的便携式血糖仪 |
US8032306B2 (en) | 2004-12-29 | 2011-10-04 | Cerner Innovation, Inc. | Computerized system and method for documenting patient vital signs during blood product administration and transfusion |
US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
EP1904943A1 (en) * | 2005-06-27 | 2008-04-02 | Novo Nordisk A/S | User interface for delivery system providing dual setting of parameters |
US20080126969A1 (en) * | 2006-08-03 | 2008-05-29 | Blomquist Michael L | Interface for medical infusion pump |
US20080172027A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having basal rate testing features |
US20080214919A1 (en) | 2006-12-26 | 2008-09-04 | Lifescan, Inc. | System and method for implementation of glycemic control protocols |
CN101342090A (zh) * | 2006-12-26 | 2009-01-14 | 生命扫描有限公司 | 用于实施血糖控制方案的系统和方法 |
US10154804B2 (en) | 2007-01-31 | 2018-12-18 | Medtronic Minimed, Inc. | Model predictive method and system for controlling and supervising insulin infusion |
US8758245B2 (en) * | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
DK2167168T3 (en) * | 2007-06-25 | 2017-06-06 | Hoffmann La Roche | INDIVIDUALIZED BASAL INSULIN ADMINISTRATION SYSTEM |
US9452258B2 (en) | 2007-10-09 | 2016-09-27 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
EP2393412B1 (en) | 2009-02-04 | 2017-08-30 | Sanofi-Aventis Deutschland GmbH | Medical device and method for providing information for glycemic control |
-
2010
- 2010-02-03 EP EP10702133.9A patent/EP2393412B1/en active Active
- 2010-02-03 EP EP17182868.4A patent/EP3254616B1/en not_active Revoked
- 2010-02-03 CN CN2010800155407A patent/CN102369029A/zh active Pending
- 2010-02-03 DK DK17182868.4T patent/DK3254616T3/da active
- 2010-02-03 AU AU2010210181A patent/AU2010210181B2/en active Active
- 2010-02-03 CA CA2750049A patent/CA2750049C/en active Active
- 2010-02-03 US US13/145,836 patent/US20120053843A1/en not_active Abandoned
- 2010-02-03 BR BRPI1008836A patent/BRPI1008836B8/pt active IP Right Grant
- 2010-02-03 CN CN201710020271.7A patent/CN106955391B/zh active Active
- 2010-02-03 CA CA3062122A patent/CA3062122C/en active Active
- 2010-02-03 WO PCT/EP2010/051264 patent/WO2010089304A1/en active Application Filing
- 2010-02-03 DK DK10702133.9T patent/DK2393412T3/en active
- 2010-02-03 BR BR122020016567-7A patent/BR122020016567B1/pt active IP Right Grant
- 2010-02-03 JP JP2011548665A patent/JP5677321B2/ja active Active
-
2011
- 2011-07-27 IL IL214317A patent/IL214317A/en active IP Right Grant
-
2017
- 2017-02-07 US US15/426,240 patent/US11135367B2/en active Active
-
2018
- 2018-06-11 HK HK18107566.9A patent/HK1248083A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20120053843A1 (en) | 2012-03-01 |
US11135367B2 (en) | 2021-10-05 |
EP2393412B1 (en) | 2017-08-30 |
BR122020016567B1 (pt) | 2021-09-28 |
JP2012516732A (ja) | 2012-07-26 |
CA3062122C (en) | 2022-05-17 |
CN106955391B (zh) | 2020-11-20 |
US20170143901A1 (en) | 2017-05-25 |
BRPI1008836B1 (pt) | 2020-12-01 |
CN106955391A (zh) | 2017-07-18 |
CA3062122A1 (en) | 2010-08-12 |
EP3254616B1 (en) | 2021-06-09 |
AU2010210181B2 (en) | 2015-01-22 |
JP5677321B2 (ja) | 2015-02-25 |
CA2750049C (en) | 2021-02-23 |
DK3254616T3 (da) | 2021-09-06 |
EP2393412A1 (en) | 2011-12-14 |
BRPI1008836A2 (pt) | 2016-03-15 |
HK1248083A1 (zh) | 2018-10-12 |
EP3254616A1 (en) | 2017-12-13 |
IL214317A0 (en) | 2011-09-27 |
CN102369029A (zh) | 2012-03-07 |
AU2010210181A1 (en) | 2011-08-25 |
IL214317A (en) | 2014-05-28 |
WO2010089304A1 (en) | 2010-08-12 |
DK2393412T3 (en) | 2017-12-11 |
CA2750049A1 (en) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1008836B8 (pt) | dispositivo e método médicos para proporcionar informações de controle glicêmico | |
BR112017024453A2 (pt) | Símbolos escalonados para uma estrutura de subquadro duplex de divisão de tempo (tdd) auto- contida | |
BR112012021572A2 (pt) | método e sistema de teste de análito com notificação de tendências de glicose sanguínea altas e baixas. | |
BR112018002040A2 (pt) | controle de uma nuvem de dispositivo | |
BR112015003509A2 (pt) | sistema de suporte clínico, meio não transitório de armazenamento legível em computador contendo instruções para execução por meio de um processador, e programa de computador | |
BR112013003751A2 (pt) | sistema e método para estimar características direcionais com base nas medidas do momento de flexão | |
MX341086B (es) | Sistema operativo de contraseña, aparato de contraseña y metodo generador de supercontraseña. | |
WO2013032515A3 (en) | Systems and methods for application identification | |
BR112014029588A2 (pt) | sistema e métodos para detectar distúrbios de saúde | |
BR112013031078A2 (pt) | emissor-receptor móvel, emissor-receptor de estação base, servidor de dados e aparelhos relacionados, métodos e programas de computadores | |
BR112014019336A2 (pt) | ambiente e método para o desenvolvimento multi-plataforma de aplicações de software | |
BR112013022076A2 (pt) | acesso de dados armazenados em memória de instrumento cirúrgico | |
MX2007004061A (es) | Uso controlado de software en una arquitectura basada en red. | |
BR112013009842A2 (pt) | processo e dispositivo de controle de um circuito de sujeição de um sistema de acionamento de geometrias variáveis de um turbo-reator | |
ES2552881B1 (es) | Dispositivo portable y método de control mediante gestos | |
AR092077A1 (es) | Sistema medico | |
BR112015000809A2 (pt) | métodos e aparelhos para integrar uma parte de componentes de elemento seguro em um sistema em chip | |
BR112015029955A2 (pt) | carga de largura parcial dependente de modo para pro-cessadores registradores mais amplos, métodos e siste-mas | |
BR112012028406A2 (pt) | método, pelo menos uma memória e pelo menos um código de programa de computador configurados, com pelo menos um processadro de dados e aparelho | |
WO2010051240A3 (en) | Individualized ranking of risk of health outcomes | |
GB201302443D0 (en) | Detecting malicious computer code in an executing program module | |
WO2008005184A3 (en) | Improvements in or relating to the copy protection of optical discs | |
BR112013006661A2 (pt) | método e aparelho para operações de lógica universal | |
AR072509A1 (es) | Procedimientos, aparatos y productos de programas informaticos para proporcionar informacion | |
BR112016013314A2 (pt) | Sistema de monitoramento médico, método para monitoramento de paciente, mídia de armazenamento legível por computador não transitória contendo software, e dispositivo de processamento de dados eletrônicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/02/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |